» Articles » PMID: 8702807

Cyclin D1 Expression is Regulated Positively by the P42/p44MAPK and Negatively by the P38/HOGMAPK Pathway

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 Aug 23
PMID 8702807
Citations 334
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that the persistent activation of p42/p44(MAPK) is required to pass the G1 restriction point in fibroblasts (Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., and Pouysségur, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8319-8323) and postulated that MAPKs control the activation of G1 cyclin-dependent complexes. We examined the mitogen-dependent induction of cyclin D1 expression, one of the earliest cell cycle-related events to occur during the G0/G1 to S-phase transition, as a potential target of MAPK regulation. Effects exerted either by the p42/p44(MAPK) or the p38/HOGMAPK cascade on the regulation of cyclin D1 promoter activity or cyclin D1 expression were compared in CCL39 cells, using a co-transfection procedure. We found that inhibition of the p42/p44(MAPK) signaling by expression of dominant-negative forms of either mitogen-activated protein kinase kinase 1 (MKK1) or p44(MAPK), or by expression of the MAP kinase phosphatase, MKP-1, strongly inhibited expression of a reporter gene driven by the human cyclin D1 promoter as well as the endogenous cyclin D1 protein. Conversely, activation of this signaling pathway by expression of a constitutively active MKK1 mutant dramatically increased cyclin D1 promoter activity and cyclin D1 protein expression, in a growth factor-independent manner. Moreover, the use of a CCL39-derived cell line that stably expresses an inducible chimera of the estrogen receptor fused to a constitutively active Raf-1 mutant (DeltaRaf-1:ER) revealed that in absence of growth factors, activation of the Raf > MKK1 > p42/p44MAPK cascade is sufficient to fully induce cyclin D1. In marked contrast, the p38(MAPK) cascade showed an opposite effect on the regulation of cyclin D1 expression. In cells co-expressing high levels of the p38(MAPK) kinase (MKK3) together with the p38(MAPK), a significant inhibition of mitogen-induced cyclin D1 expression was observed. Furthermore, inhibition of p38(MAPK) activity with the specific inhibitor, SB203580, enhanced cyclin D1 transcription and protein level. Altogether, these results support the notion that MAPK cascades drive specific cell cycle responses to extracellular stimuli, at least in part, through the modulation of cyclin D1 expression and associated cdk activities.

Citing Articles

Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer.

Asciolla J, Wu X, Adamopoulos C, Gavathiotis E, Poulikakos P Nat Cancer. 2025; 6(1):24-40.

PMID: 39885369 DOI: 10.1038/s43018-024-00893-z.


CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells.

Lim S, Lee S, Hong J, Lee J, Kim S Transl Cancer Res. 2024; 13(7):3695-3703.

PMID: 39145064 PMC: 11319972. DOI: 10.21037/tcr-24-20.


Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in - and -mutant cancer cells.

Zhang H, Read A, Cataisson C, Yang H, Lee W, Turk B Sci Signal. 2024; 17(836):eadd5073.

PMID: 38743809 PMC: 11238902. DOI: 10.1126/scisignal.add5073.


ITPR2 Mediated Calcium Homeostasis in Oligodendrocytes is Essential for Myelination and Involved in Depressive-Like Behavior in Adolescent Mice.

Zhang M, Zhi N, Feng J, Liu Y, Zhang M, Liu D Adv Sci (Weinh). 2024; 11(20):e2306498.

PMID: 38476116 PMC: 11132048. DOI: 10.1002/advs.202306498.


Modelling the disease: HS-sensitivity and drug-resistance of triple negative breast cancer cells can be modulated by embedding in isotropic micro-environment.

Buonvino S, Arciero I, Martinelli E, Seliktar D, Melino S Mater Today Bio. 2023; 23:100862.

PMID: 38046276 PMC: 10689286. DOI: 10.1016/j.mtbio.2023.100862.